Humana and DrFirst Partner on Innovation to Fill Gaps in Care, Improve Outcomes for Patients with Diabetes and Other Chronic Conditions
Humana (NYSE: HUM) and DrFirst have announced a strategic partnership to enhance care for patients with chronic conditions like diabetes and cardiovascular disease. The initiative's first phase focuses on increasing statin therapy adoption among eligible patients, aligning with CMS quality metrics.
The program leverages DrFirst's prescription orchestration platform, enabling real-time clinical collaboration between healthcare stakeholders. Providers can receive and act on prescription recommendations with a single click, streamlining the workflow process. The platform is integrated with over 270 EHR systems, facilitating rapid implementation across various care settings.
This collaboration extends the companies' decade-long partnership, which previously introduced the first real-time prescription benefit tool in 2015.
Humana (NYSE: HUM) e DrFirst hanno annunciato una partnership strategica per migliorare l'assistenza ai pazienti con condizioni croniche come diabete e malattie cardiovascolari. La prima fase dell'iniziativa 猫 mirata ad aumentare l'adozione della terapia con statine tra i pazienti idonei, in linea con i parametri di qualit脿 della CMS.
Il programma sfrutta la piattaforma di orchestrazione delle prescrizioni di DrFirst, permettendo una collaborazione clinica in tempo reale tra gli operatori sanitari. I fornitori possono ricevere e applicare raccomandazioni di prescrizione con un solo clic, semplificando il flusso di lavoro. La piattaforma 猫 integrata con oltre 270 sistemi EHR, agevolando un'implementazione rapida in diversi contesti assistenziali.
Questa collaborazione amplia la partnership decennale tra le aziende, che nel 2015 aveva introdotto il primo strumento di verifica dei benefici delle prescrizioni in tempo reale.
Humana (NYSE: HUM) y DrFirst han anunciado una alianza estrat茅gica para mejorar la atenci贸n de pacientes con enfermedades cr贸nicas como la diabetes y las enfermedades cardiovasculares. La primera fase de la iniciativa se centra en aumentar la adopci贸n de la terapia con estatinas entre los pacientes elegibles, en consonancia con los indicadores de calidad de la CMS.
El programa aprovecha la plataforma de orquestaci贸n de recetas de DrFirst, permitiendo una colaboraci贸n cl铆nica en tiempo real entre los actores sanitarios. Los proveedores pueden recibir y actuar sobre recomendaciones de prescripci贸n con un solo clic, agilizando el flujo de trabajo. La plataforma est谩 integrada con m谩s de 270 sistemas EHR, lo que facilita una implementaci贸n r谩pida en distintos entornos asistenciales.
Esta colaboraci贸n ampl铆a la alianza de m谩s de una d茅cada entre las compa帽铆as, que en 2015 introdujeron la primera herramienta de beneficios de prescripci贸n en tiempo real.
Humana (NYSE: HUM)鞕� DrFirst電� 雼闺嚚氤� 氚� 鞁槇甏� 歆堩櫂瓿� 臧欖潃 毵岇劚 歆堩櫂 頇橃瀽鞐� 雽�頃� 旃橂毳� 臧曧檾頃橁赴 鞙勴暅 鞝勲灥鞝� 韺岉姼雱堨嫮鞚� 氚滍憸頄堨姷雼堧嫟. 鞚� 鞚措媹靺旐嫲敫岇潣 觳� 雼硠電� CMS鞚� 頀堨 歆�響滌檧 鞚检箻頃橂弰搿� 鞝侁博 頇橃瀽霌� 靷澊鞐愳劀 鞀ろ儉韹� 旃橂 毂勴儩鞚� 電橂Μ電� 雿� 欷戩爯鞚� 霊‰媹雼�.
鞚� 頂勲攴鸽灗鞚� DrFirst鞚� 觳橂癌 鞓れ紑鞀ろ姼霠堨澊靺� 頂岆灚韽检潉 頇滌毄頃橃棳 鞚橂 鞚错暣甏�瓿勳瀽 臧勳潣 鞁れ嫓臧� 鞛勳儊 順戩梾鞚� 臧�電ロ晿瓴� 頃╇媹雼�. 鞝滉车鞛愲姅 觳橂癌 甓岅碃毳� 頃� 氩堨潣 韥措Ν鞙茧 氚涥碃 鞁ろ枆頃� 靾� 鞛堨柎 鞗岉伂頂岆臧� 臧勳唽頇旊惄雼堧嫟. 鞚� 頂岆灚韽检潃 270臧� 鞚挫儊鞚� EHR 鞁滌姢韰�瓿� 韱淀暕霅橃柎 雼れ枒頃� 歆勲 頇橁步鞐愳劀 牍犽ゴ瓴� 霃勳瀰霅� 靾� 鞛堨姷雼堧嫟.
鞚措矆 順戩梾鞚� 鞏戩偓鞚� 10雲勳澊 雱橂姅 韺岉姼雱堨嫮鞚� 頇曥灔頃橂姅 瓴冹溂搿�, 鞏戩偓電� 2015雲勳棎 斓滌磮鞚� 鞁れ嫓臧� 觳橂癌 順滍儩 霃勱惮毳� 靹犽炒鞚� 氚� 鞛堨姷雼堧嫟.
Humana (NYSE: HUM) et DrFirst ont annonc茅 un partenariat strat茅gique pour am茅liorer les soins aux patients atteints de maladies chroniques telles que le diab猫te et les affections cardiovasculaires. La premi猫re phase de l'initiative vise 脿 accro卯tre l'adoption des traitements par statines chez les patients 茅ligibles, en conformit茅 avec les indicateurs de qualit茅 de la CMS.
Le programme s'appuie sur la plateforme d'orchestration des prescriptions de DrFirst, permettant une collaboration clinique en temps r茅el entre les acteurs de sant茅. Les prestataires peuvent recevoir et appliquer des recommandations de prescription en un seul clic, ce qui simplifie les flux de travail. La plateforme est int茅gr茅e 脿 plus de 270 syst猫mes EHR, facilitant un d茅ploiement rapide dans divers contextes de soins.
Cette collaboration prolonge un partenariat de plus de dix ans entre les deux soci茅t茅s, qui avait d茅j脿 lanc茅 en 2015 le premier outil de b茅n茅fices de prescription en temps r茅el.
Humana (NYSE: HUM) und DrFirst haben eine strategische Partnerschaft angek眉ndigt, um die Versorgung von Patienten mit chronischen Erkrankungen wie Diabetes und Herz-Kreislauf-Erkrankungen zu verbessern. Die erste Phase der Initiative konzentriert sich darauf, die Anwendung von Statintherapien bei berechtigten Patienten zu steigern und entspricht den Qualit盲tskennzahlen der CMS.
Das Programm nutzt die Rezeptorchestrierungsplattform von DrFirst und erm枚glicht so eine Echtzeit-Kollaboration zwischen den Gesundheitsakteuren. Leistungserbringer k枚nnen Verschreibungsempfehlungen mit einem Klick erhalten und umsetzen, wodurch Arbeitsabl盲ufe vereinfacht werden. Die Plattform ist in 眉ber 270 EHR-Systeme integriert und erleichtert so eine schnelle Implementierung in unterschiedlichen Versorgungsumgebungen.
Die Zusammenarbeit baut auf der mehr als zehnj盲hrigen Partnerschaft der Unternehmen auf, die bereits 2015 das erste Echtzeit-Tool f眉r Verschreibungs-Benefits eingef眉hrt hatten.
- Integration with over 270 EHR systems enables broad implementation
- One-click prescription approval system streamlines provider workflow
- Platform enables real-time collaboration between healthcare stakeholders
- Program aligns with CMS quality metrics for better patient outcomes
- None.
Insights
Humana's partnership with DrFirst to boost statin therapy compliance enhances care quality metrics and supports Medicare reimbursement optimization.
Humana's new partnership with DrFirst represents a strategic initiative to address critical gaps in medication adherence, specifically targeting statin therapy for patients with diabetes and cardiovascular disease. This collaboration directly supports Humana's performance on CMS quality metrics, which increasingly influence reimbursement rates in Medicare Advantage plans.
The technology enables a workflow innovation that could meaningfully improve physician adoption rates compared to traditional gap-in-care notifications. By integrating recommendations directly into the e-prescribing workflow across 270+ EHR systems, Humana can influence prescribing behavior at the point of care 鈥� when providers are most likely to take action.
From a business perspective, this program addresses multiple strategic objectives: it potentially reduces medical costs by improving cardiovascular outcomes through statin therapy, enhances Humana's quality ratings (which impact Medicare Advantage star ratings and subsequent reimbursements), and strengthens provider relationships by offering workflow solutions rather than administrative burdens.
The technology builds upon their decade-long collaboration that pioneered real-time prescription benefit tools in 2015, demonstrating Humana's continued commitment to technology-enabled care improvement. For Humana, whose Medicare Advantage business faces ongoing market pressures, initiatives that simultaneously improve clinical outcomes while potentially boosting star ratings represent a valuable competitive approach in the increasingly value-based healthcare ecosystem.
Program Designed to Increase Use of Recommended Medication Therapy by Connecting with Providers in Workflow
The use of statins for certain Medicare patients is associated with lower cardiovascular risk, better outcomes and reduced health care costs. To address this, Humana is partnering with DrFirst to connect with prescribers within the clinical workflow. Using the DrFirst prescription orchestration platform, Humana can now initiate new prescription recommendations for these high-risk patients and submit them to the health care provider for consideration. With one click, the provider can approve the prescription recommendation and generate a new prescription or note why it is not an appropriate choice for the patient.
"We're not just flagging care opportunities鈥攚e're making sure they get to providers in a way that's timely and easy to act on," said Bethanie Stein, Pharm.D., President, Pharmacy at Humana. "By reaching providers in their workflow, we're freeing them to focus on patient care, which in turn can help address gaps in care, promote quality and lead to better health outcomes."
The DrFirst prescription orchestration platform is a smart, flexible solution that turns disconnected workflows into real-time clinical collaboration. The rules-based system enables real-time interoperability among health care stakeholders鈥攊ncluding health care providers, pharmacies, and payers鈥攖o close critical gaps in patient information and collaborate to improve patient outcomes.
"This partnership is about more than innovative technology; it's about better patient outcomes," said Laizer Kornwasser, DrFirst CEO. "As a company dedicated to taking the friction out of health care, it's especially meaningful to introduce an entirely new approach to medication management." Because DrFirst e-prescribing technology is used in over 270 EHRs, the prescription orchestration platform can be quickly implemented in workflow across care settings.
The collaboration builds on a decade-long track record of innovation between Humana and DrFirst. In 2015, the companies partnered to introduce the first real-time prescription benefit tool, enabling providers to view patient-specific coverage, costs and prior authorization requirements at the point of prescribing.
About Humana
Humana Inc. (NYSE: HUM) is committed to putting health first 鈥� for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health 鈥� delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at聽聽and at聽
About DrFirst
For 25 years, healthcare IT pioneer DrFirst has empowered providers and patients to achieve better health through intelligent medication management. We improve healthcare workflows and help patients start and stay on therapy with end-to-end solutions that enhance prescription access, affordability, and adherence. DrFirst has recently won over 25 awards for excellence and innovation, including winning Gold in the prestigious Edison Awards in 2023, recognizing our game-changing use of clinical-grade AI to streamline time-consuming healthcare workflows and prevent medication errors. Our solutions help 100 million patients a year and are used by more than 450,000 prescribers, 71,000 pharmacies, 270 EHRs and health information systems, and over 2,000 hospitals in the
Media contact:
DrFirst:
Katlyn Nesvold, Amendola Communications
PH 715-559-0046 [email protected]
Humana:
Mark Mathis
Humana Corporate Communications
[email protected]
View original content to download multimedia:
SOURCE DrFirst
FAQ
What is the purpose of Humana's partnership with DrFirst in 2025?
How does Humana's new prescription orchestration platform work with healthcare providers?
How many EHR systems is DrFirst's technology integrated with?
What was the previous collaboration between Humana and DrFirst?
How does the new Humana-DrFirst program align with CMS requirements?
